Adma Biologics (ADMA) EPS (Basic) Growth (1y) (2012 - 2025)
Adma Biologics (ADMA) EPS (Basic) Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -361.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -361.41% |
| Sep 30, 2025 | -0.27% |
| Jun 30, 2025 | 2.72% |
| Mar 31, 2025 | 45.44% |
| Dec 31, 2024 | 352.33% |
| Sep 30, 2024 | 1,244.49% |
| Jun 30, 2024 | 582.17% |
| Mar 31, 2024 | 354.31% |
| Dec 31, 2023 | 150.22% |
| Sep 30, 2023 | 115.02% |
| Jun 30, 2023 | 59.13% |
| Mar 31, 2023 | 67.02% |
| Dec 31, 2022 | 47.72% |
| Sep 30, 2022 | 42.80% |
| Jun 30, 2022 | 52.61% |
| Mar 31, 2022 | 41.49% |
| Dec 31, 2021 | 29.08% |
| Sep 30, 2021 | 31.18% |
| Jun 30, 2021 | 36.77% |
| Mar 31, 2021 | 39.20% |